Novo Nordisk study shows Wegovy can cut heart attack and stroke risk |
|
A study conducted by Novo Nordisk (NVO) shows that the drugmaker's obesity drug Wegovy can slash the risk of serious heart problems, like heart attacks and strokes, by up to 20 percent. Yahoo Finance Health Care Reporter Anjalee Khemlani explains the study's findings, comparing Wegovy to other pharmaceutical developers' weight-loss drugs.
#yahoofinance #youtube #weightloss Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more. To learn more about Yahoo Finance Plus please visit: https://yhoo.it/33jXYBp Connect with Yahoo Finance: Get the latest news: https://yhoo.it/2fGu5Bb Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV |